Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: A retrospective analysis

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Tsavaris, Nikolas ^a   Kavantzas, Nicolaos ^a   Tsigritis, Kostantinos ^a   Xynos, Ioannis D ^a   Papadoniou, Nikitas ^a,d   Lazaris, Andreas ^a   Kosmas, Christos ^b   Agrogiannis, George ^a   Dokou, Anna ^a   Felekouras, Evangelos ^a   Antoniou, Efstathios ^a   Polyzos, Aris ^a   Sarantonis, John ^a   Tsipras, Heracles ^c   Karatzas, Gavrilos ^a   Papalambros, Alexandros ^a   Patsouris, Efstratios S ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b METAXA CANCER HOSPITAL   (Greece)

^c G GENNIMATAS GENERAL HOSPITAL   (Greece)

^d Andreas Papandreou General Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CELL DNA; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURVIVAL; DISTANT METASTASIS; DNA CONTENT; FEMALE; HUMAN; INOPERABLE CANCER; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PANCREAS ADENOCARCINOMA; PHYSICAL PERFORMANCE; PLOIDY; PROGNOSIS; RETROSPECTIVE STUDY; STEATORRHEA; SURVIVAL TIME; WEIGHT REDUCTION; ADENOCARCINOMA; GENETICS; METASTASIS; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; PATHOLOGY; SURVIVAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; PLOIDIES; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL;

EID: 69849113151     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-264     Document Type: Article

References (43)

1. Jemal A Murray T Ward E Samuels A Tiwari RC Ghafoor A Feuer EJ Thun MJ Cancer statistics, 2005 CA Cancer J Clin 2005, 55:10-30 10.3322/ canjclin.55.1.10 15661684
2. Anderson KE Potter JD Mack TM Pancreatic cancer Cancer Epidemiology and prevention New York: Oxford University Press Schottenfeld D, Fraumeni JF Jr 2005:725-771
3. Niederhuber JE Brennan MF Menck HR The National Cancer Data Base Report on pancreatic cancer Cancer 1995, 76:1671-1677 10.1002/ 1097-0142(19951101)76:9<1671::AID-CNCR2820760926>3.0.CO;2-R 8635074
4. Reber HA Gloor B Radical pancreatectomy Surg Oncol Clin North Am 1998, 7:157-163
5. Fong Y Blumgart LH Fortner JG Brennan MF Pancreatic or liver resection for malignancy is safe and effective for the elderly Ann Surg 1995, 222:426-437 10.1097/00000658-199522240-00002 1234870 7574924
6. Yeo CJ Cameron JL Sohn TA Lillemoe KD Pitt HA Talamini MA Hruban RH Ord SE Sauter PK Coleman J Zahurak ML Grochow LB Abrams RA Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: Pathology, complications, and outcomes Ann Surg 1997, 226:248-60 10.1097/ 00000658-199709000-00004 1191017 9339931
7. Conlon KC Klimstra DS Brennan MF Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors Ann Surg 1996, 223:273-279 10.1097/ 00000658-199603000-00007 1235115 8604907
8. Sperti C Pasquali C Piccoli A Pedrazzoli S Survival after resection for ductal adenocarcinoma of the pancreas Br J Surg 1996, 83:625-631 10.1002/ bjs.1800830512 8689203
9. Magistrelli P Antinori A Crucitti A Le Greca A Masetti R Coppola R Nuzzo G Picciocchi A Prognostic factors after surgical resection for pancreatic carcinoma J Surg Oncol 2000, 74:36-40 10.1002/ 1096-9098(200005)74:1<36::AID-JSO9>3.0.CO;2-F 10861607
10. Matsuno S Egawa S Shibuya K Shimamura H Sunamura M Takeda K Katoh H Okada S Suda K Nakao A Isaji S Hiraoka T Hosotani R Imaizumi T Pancreatic cancer: Current status of treatment and survival of 16071 patients diagnosed from 1981-using the Japanese National Pancreatic Cancer Database Int J Clin Oncol 1996, 5:153-157 10.1007/PL00012030
11. Smith AC Dowsett JF Russell RC Hatfield AR Cotton RB Randomised trial of endoscopic stending versus surgical bypass in malignant low bileduct obstruction Lancet 1994, 344:1655-1660 10.1016/S0140-6736(94)90455-3 7996958
12. Lillemoe KD Pitt HA Palliation. Surgical and otherwise Cancer 1996, 78(3 Suppl):605-14 8681299
13. Link KH Gansauge F Goerich J Leder G Rillinger N Berger HG Palliative and adjuvant regional chemotherapy in pancreatic cancer Eur J Surg Oncol 1997, 23:409-414 10.1016/S0748-7983(97)93720-3 9393568
14. Kalser MH Barkin J MacIntyre JM Pancreatic cancer. Assessment of prognosis by clinical presentation Cancer 1985, 56:397-402 10.1002/ 1097-0142(19850715)56:2<397::AID-CNCR2820560232>3.0.CO;2-I 4005804
15. Falconer JS Fearon KC Ross JA Elton R Wigmore SJ Garden OJ Carter DC Acute-phase protein response and survival duration of patients with pancreatic cancer Cancer 1995, 75:2077-82 10.1002/ 1097-0142(19950415)75:8<2077::AID-CNCR2820750808>3.0.CO;2-9 7535184
16. Ishii H Okada S Nose H Yoshimori M Aoki K Okusaka T Prognostic factors in patients with advanced pancreatic cancer treated with systemic chemotherapy Pancreas 1996, 12:267-71 10.1097/00006676-199604000-00009 8830333
17. Kau SY Shyr YM Su CH Wu CW Lui WY Diagnostic and prognostic values of CA 19-9 and CEA in periampullary cancers J Am Coll Surg 1999, 188:415-20 10.1016/S1072-7515(98)00326-3 10195726
18. Terwee CB Nieveen Van Dijkum EJ Gouma DJ Bakkevold KE Klinkenbijl JH Wade TP van Wagensveld BA Wong A Meulen van der JH Pooling of prognostic studies in cancer of the pancreatic head and periampullary region: The Triple-P study. Triple-P study group Eur J Surg 2000, 166:706-12 10.1080/ 110241500750008466 11034467
19. Ikeda M Okada S Tokuuye K Ueno H Okusaka T Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy Cancer 2001, 91:490-5 10.1002/ 1097-0142(20010201)91:3<490::AID-CNCR1027>3.0.CO;2-L 11169931
20. Saad ED Machado MC Wajsbrot D Abramoff R Hoff PM Tabacof J Katz A Simon SD Gansl RC Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine Int J Gastrointest Cancer 2002, 32:35-41 10.1385/IJGC:32:1:35 12630768
21. Engelken FJ Bettschart V Rahman MQ Parks RW Garden OJ Prognostic factors in the palliation of pancreatic cancer Eur J Surg Oncol 2003, 29:368-73 10.1053/ejso.2002.1405 12711291
22. Watanabe I Sasaki S Konishi M Nakagohri T Inoue K Oda T Kinoshita T Onset symptoms and tumor locations as prognostic factors of pancreatic cancer Pancreas 2004, 28:160-5 10.1097/00006676-200403000-00007 15028948
23. Sezgin C Karabulut B Uslu R Sanli UA Goksel G Yuzer Y Goker E Gemcitabine treatment in patients with inoperable locally advanced/ metastatic pancreatic cancer and prognostic factors Scand J Gastroenterol 2005, 40:1486-92 10.1080/00365520510023819 16293561
24. Krishnan S Rana V Janjan NA Abbruzzese JL Gould MS Das P Delclos ME Palla S Guha S Varadhachary G Evans DB Wolff RA Crane CH Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation Cancer 2006, 107:2589-96 10.1002/cncr.22328 17083124
25. Maréchal R Demols A Gay F De Maertelaere V Arvanitaki M Hendlisz A Van Laethem JL Prognostic factors and prognostic index for chemonaïve and gemcitabine-refractory patients with advanced pancreatic cancer Oncology 2007, 73:41-51 10.1159/000120627 18334830
26. Park JK Yoon YB Kim YT Ryu JK Yoon WJ Lee SH Survival and prognostic factors of unresectable pancreatic cancer J Clin Gastroenterol 2008, 42:86-91 10.1097/01.mcg.0000225657.30803.9d 18097296
27. Howe JR Conlon KC The molecular genetics of pancreatic cancer Surg Oncol 1997, 6:1-18 10.1016/S0960-7404(97)00001-7 9364657
28. Papadoniou N Kosmas C Gennatas K Polyzos A Mouratidou D Skopelitis E Tzivras M Sougioultzis S Papastratis G Karatzas G Papalambros E Tsavaris N Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: A retrospective analysis Anticancer Res 2008, 28:543-9 18383900
29. Kloppel G Solcia E Longnecker DS Capella C Sobin LH Histological Typing of Tumours of the Exocrine Pancreas. WHO International Histological Classification of Tumours Berlin, Springer-Verlag 2 1996
30. Sobin LH Wittekind Ch eds UICC TNM Classification of Malignant Tumors New York, John Wiley & Sons, Inc 5 1997
31. Weger AR Mikuz G Askensten U Auer GU Schwab G Glaser KS Methodological aspects of DNA image cytometry in formalin-fixed paraffin-embedded material from pancreatic adenocarcinoma Pathol Res Pract 1989, 185:752-4 2696952
32. Böttger TC Störkel S Wellek S Stöckle M Junginger T Factors influencing survival after resection of pancreatic cancer. A DNA analysis and a histomorphologic study Cancer 1994, 73:63-73 10.1002/ 1097-0142(19940101)73:1<63::AID-CNCR2820730113>3.0.CO;2-P 8275439
33. Yeo CJ Cameron JL Lillemoe KD Sitzmann JV Hruban RH Goodman SN Dooley WC Coleman J Pitt HA Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients Ann Surg 1995, 221:721-733 10.1097/ 00000658-199506000-00011 1234702 7794076
34. Porschen R Remy U Bevers G Schauseil S Hengels KJ Borchard F Prognostic significance of DNA ploidy in adenocarcinoma of the pancreas. A flow cytometric study of paraffin-embedded specimens Cancer 1993, 71:3846-50 10.1002/1097-0142(19930615 71:12<3846::AID-CNCR2820711209>3.0.CO;2-I 8508352
35. Alanen KA Joensuu H Klemi PJ Nevalainen TG Clinical significance of nuclear DNA content in pancreatic carcinoma Journal of Pathology 1990, 160:313-320 10.1002/path.1711600407 2358969
36. Yoshimura T Manabe T Imamura T Imanishi K Ohshio G Yamabe H Kitamura O Matsumoto M Ogasahara K Takasan H Flow cytometric analysis of nuclear DNA content of duct cell carcinoma of the pancreas Cancer 1992, 70:1069-74 10.1002/ 1097-0142(19920901)70:5<1069::AID-CNCR2820700510>3.0.CO;2-U 1325268
37. Schlichting E Clausen OPF Hanssen AS Buanes TA Ploidy and survival in respectable pancreatic cancers Eur J Surg 1993, 159:229-233 8102544
38. Rugge M Sonego F Sessa F Leandro G Capella C Sperti C Pasquali C Di Mario F Pedrazzoli S Ninfo V Nuclear DNA content and pathology in radically treated pancreatic carcinoma. The prognostic significance of DNA ploidy, histology and nuclear grade Cancer 1996, 77:459-66 10.1002/ (SICI)1097-0142(19960201)77:3<459::AID-CNCR6>3.0.CO;2-F 8630952
39. He YC Qiao JG Cao J Chen JW Relationship between nuclear morphometry, DNA content and respectability of pancreatic cancer World J Gastroenterol 2003, 9:1863-65 12918140
40. Baisch H Klöppel G Reinke B DNA ploidy and cell-cycle analysis in pancreatic and ampullary carcinoma: Flow cytometric study of formalin-fixed paraffin-embedded tissue Virchows Arch A Pathol Anat Histopathol 1990, 417:145-50 10.1007/BF02190532 2114693
41. Herrera MF van Heerden JA Katzmann JA Weiland LH Nagorney DM Ilstrup D Evaluation of DNA nuclear pattern as a prognostic determinant in resected pancreatic ductal adenocarcinoma Ann Surg 1992, 215:120-4 10.1097/00000658-199202000-00005 1242398 1312318
42. Stoecklein NH Luebke AM Erbersdobler A Knoefel WT Schraut W Verde PE Stern F Scheunemann P Peiper M Eisenberger CF Izbicki JR Klein CA Hosch SB Copy number of chromosome 17 but not HER2 amplification predicts clinical outcome of patients with pancreatic ductal adenocarcinoma J Clin Oncol 2004, 1:4737-45 Erratum in: J Clin Oncol 2005, 23:248 10.1200/ JCO.2004.05.142
43. Berczi C Bocsi J Lapis K Balázs G Relationship between the survival and the clinicopathological parameters of the patients with tumors in the pancreatic head region Acta Chir Hung 1999, 38:235-41 10935131